Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68001-247
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68001-247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ondasetron Orally Disintegrating Tablets Usp 4mg (Ondansetron Od Tablets Usp 4mg 30 Tablets Labels Rev 12 21)
Ondansetron Od Tabs Usp 4mg Label Rev 01-26 (Ondansetron Od Tabs Usp 4mg Label Rev 01 26)
Ondasetron Orally Disintegrating Tablets (Ondansetron Od Tablets Usp 8mg 30 Tablets Labels Rev 12 21)
Ondansetron Od Tabs Usp 8mg Label Rev 01-26 (Ondansetron Od Tabs Usp 8mg Label Rev 01 26)
Ondansetron Orally Disintegrating Tablets (Ondansetron Od Tablets Usp 8mg Carton Rev 11 21)
Ondansetron Od Tabs Usp 8mg Carton Rev 04-26 (Ondansetron Od Tabs Usp 8mg Carton Rev 04 26)
Ondansetron Orally Disintegrating Tablets (Ondansetron Od Tablets Usp 4mg Carton Rev 11 21)
Ondansetron Od Tabs Usp 4mg Carton Rev 04-26 (Ondansetron Od Tabs Usp 4mg Carton Rev 04 26)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.